Samsara BioCapital »

Eloxx Pharmaceuticals shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Eloxx Pharmaceuticals shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Eloxx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eloxx Pharmaceuticals held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eloxx Pharmaceuticals by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 400k 13.88

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Alumis (ALMS)
Mineralys Therapeutics (MLYS)
Septerna (SEPN)
Alamar Biosciences Common Stock
Neurogene (NGNE)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs (SGP)
Sutro Biopharma Com Shs (STRO)
Inventiva Sa Ads (IVA)
Jade Biosciences Com New (JBIO)
Parabilis Medicines
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
Nkarta (NKTX)

View all positions for Samsara BioCapital

Top funds holding Eloxx Pharmaceuticals

Stonepine Capital Management
Nantahala Capital Management
Standard Life Aberdeen
Samsara BioCapital
Vanguard Capital Management
Vanguard Fiduciary Trust
Vanguard Global Advisers
Wells Fargo & Company
Pioneer Family Office
Altshuler Shaham
Barclays
Old Point Trust & Financial Services N A
Activest Wealth Management

View all funds holding Eloxx Pharmaceuticals